Law360 Healthcare Authority: Healthcare Authority Deals & Corporate Governance /healthcare-authority/deals-corporate-governance?utm_source=rss&utm_medium=rss&utm_campaign=section Latest articles for: Healthcare Authority Deals & Corporate Governance Copyright 2025 sa¹ú¼Ê´«Ã½. en-US Tue, 24 Jun 2025 22:38:17 +0000 Healthcare Deals This Week: Sanofi, Abridge, Royalty Pharma /healthcare-authority/deals-corporate-governance/articles/2356793?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2356793 The past week marked a busy period for dealmaking in the healthcare industry, with major partnerships and M&A announcements from companies like Royalty Pharma, Sanofi and Otsuka. Tue, 24 Jun 2025 17:39:40 +0000 AI Healthcare Startup Abridge Raises $300M Series E /healthcare-authority/deals-corporate-governance/articles/2357043?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2357043 Generative artificial intelligence company Abridge has raised $300 million in a fresh round of capital, the company announced Tuesday. Tue, 24 Jun 2025 15:14:33 +0000 Cataract Surgery Tech Co. Secures $125M Series B Funding /healthcare-authority/deals-corporate-governance/articles/2356732?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2356732 Ophthalmic robotic surgery company ForSight Robotics on Tuesday revealed that it completed fundraising for its Series B financing round after securing $125 million from investors. Tue, 24 Jun 2025 14:50:00 +0000 A Midyear Review: Healthcare Dealmaking Trends Of 2025 /healthcare-authority/deals-corporate-governance/articles/2353802?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2353802 Law360 Healthcare Authority reviews key trends that helped shape dealmaking activity in the healthcare industry so far this year. Tue, 24 Jun 2025 14:03:25 +0000 Goodwin Procter Adds PE Firm General Counsel In NY /healthcare-authority/deals-corporate-governance/articles/2356796?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2356796 Goodwin Procter LLP has added the former general counsel of private equity firm Gurnet Point Capital to bolster its life sciences and healthcare practice groups. Tue, 24 Jun 2025 10:42:06 +0000 How Ore. Law Puts New Confines On Corp. Health Ownership /healthcare-authority/deals-corporate-governance/articles/2356589?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2356589 A newly enacted law in Oregon strengthens the state’s restrictions on corporate ownership of healthcare practices, with new limitations on overlapping control, permissible services, restrictive covenants and more making it necessary for practices to review decades-old physician practice arrangements, say attorneys at Ropes & Gray. Mon, 23 Jun 2025 21:13:33 +0000 Teladoc Says Investor Suit Over User Losses Is 'Illogical' /healthcare-authority/deals-corporate-governance/articles/2356107?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2356107 Telemedicine giant Teladoc Health Inc. and two of its executives seek to shed a proposed investor class action, telling a New York federal judge the shareholder suit makes "illogical" claims that they lied about post-pandemic increases in customer acquisition costs for the company's flagship mental health counseling platform. Fri, 20 Jun 2025 21:54:52 +0000 Ga. Panel Says Suit To Collect $12.1M Judgment Too Late /healthcare-authority/deals-corporate-governance/articles/2355814?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2355814 The Georgia Court of Appeals on Friday said a trial court rightly found Mariner Healthcare Management Co.'s lawsuit against Sovereign Healthcare LLC over the recovery of a $12.1 million judgment was barred by the state's four-year statute of limitations for fraud. Fri, 20 Jun 2025 17:16:48 +0000 Trump Antitrust Shift Eases Pressure On Private Equity Deals /healthcare-authority/deals-corporate-governance/articles/2352661?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2352661 Enforcement actions and statements by Trump administration antitrust officials forecast a shift away from specifically targeting private equity activity, which should be welcome news to dealmakers, but firms shouldn't expect to escape traditional antitrust scrutiny, says Nathaniel Bronstein at Fried Frank. Fri, 20 Jun 2025 14:01:14 +0000 Taxation With Representation: Latham, Paul Weiss, Covington /healthcare-authority/deals-corporate-governance/articles/2355754?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2355754 In this week's Taxation With Representation, Nippon Steel closes its purchase of U.S. Steel, Hunter Point Capital buys a minority stake in Equitix, Eaton acquires Ultra PCS Ltd. from the Cobham Ultra Group, and Eli Lilly and Co. acquires Verve Therapeutics. Wed, 18 Jun 2025 22:06:39 +0000 Ga. Panel Affirms Emory's Early Win In Neonatal Care Suit /healthcare-authority/deals-corporate-governance/articles/2354942?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2354942 The Georgia Court of Appeals said a trial court rightly freed Emory Healthcare from a suit alleging that a nurse in the neonatal intensive care unit failed to spot an intravenous line infiltration that left a newborn with skin and tissue deformities. Wed, 18 Jun 2025 21:25:11 +0000 Spectrum Pharma Investors Get First OK For $16M Deal /healthcare-authority/deals-corporate-governance/articles/2355143?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2355143 A Nevada federal judge has given the first green light to a nearly $16 million settlement between a pharmaceutical company and a class of investors who claimed the company and its executives overstated the status of two of its developed drugs and withheld negative data and trial results, leading to a stock drop when the truth was revealed. Wed, 18 Jun 2025 21:12:32 +0000 Attorneys Say Look Before Leaping Back Into Senior Housing /healthcare-authority/deals-corporate-governance/articles/2355285?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2355285 Attorneys advising on senior housing deals are seeing more interest from investors and developers, due to demographic trends and the post-pandemic recovery, but emphasize the unique legal considerations of a sector that straddles healthcare and real estate. Wed, 18 Jun 2025 18:41:02 +0000 FDA Dodges Suit Over Ozempic, Wegovy Listing /healthcare-authority/deals-corporate-governance/articles/2354725?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2354725 The U.S. Food and Drug Administration was able to escape allegations that it catered to Big Pharma by nixing cheaper versions of the miracle weight loss drug Ozempic, after a Texas federal judge tossed a lawsuit from two compounding pharmacies. Wed, 18 Jun 2025 14:42:27 +0000 InnovAge IPO Investors Get Initial OK Of $27M Settlement /healthcare-authority/deals-corporate-governance/articles/2354940?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2354940 A Colorado federal judge has preliminarily approved a $27 million settlement between InnovAge Holding Corp., its underwriters and a class of stockholders accusing the senior-health care company of making misleading statements in an initial public offering that later caused stock prices to tank after a government audit exposed the falsehoods. Tue, 17 Jun 2025 22:56:31 +0000 Cancer Diagnostics Firm, Insurer Price 2 IPOs Totaling $902M /healthcare-authority/deals-corporate-governance/articles/2354319?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2354319 Cancer-diagnostics test provider Caris Life Sciences Inc. and coastal-focused residential insurer Slide Insurance Holdings Inc. will begin trading Wednesday after pricing two initial public offerings that raised a combined $902 million, guided by five law firms. Tue, 17 Jun 2025 18:01:51 +0000 Oregon's Corporate Ownership Law Puts PE At Crossroads /healthcare-authority/deals-corporate-governance/articles/2353795?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2353795 A new law in Oregon is leaving private equity firms and other organizations at a crossroads as they try to figure out how to navigate stricter rules focused on corporate ownership of healthcare practices. Tue, 17 Jun 2025 15:47:53 +0000 Surgery Partners Rejects $3.3B Bain Offer, Eyes Public Growth /healthcare-authority/deals-corporate-governance/articles/2354279?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2354279 Surgery Partners, a short-stay surgical facility owner, said on Tuesday it has ended talks with Bain Capital regarding a nearly $3.3 billion take-private proposal, saying it sees a stronger future as a public company. Tue, 17 Jun 2025 13:16:16 +0000 Kirkland-Led Lilly Inks $1.3B Deal For Cardio Drug Co. Verve /healthcare-authority/deals-corporate-governance/articles/2354260?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2354260 Kirkland-advised Eli Lilly and Co. said Tuesday it will acquire Paul Weiss-advised Verve Therapeutics in a deal worth up to $1.3 billion, continuing its push into next-generation genetic medicines for heart disease. Fri, 13 Jun 2025 21:37:07 +0000 AbbVie Sues Colo. Over State Discount Drug Law /healthcare-authority/deals-corporate-governance/articles/2353360?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2353360 AbbVie Inc. on Thursday filed suit in Colorado federal court seeking to block an incoming state law it alleges conflicts with the federal 340B drug discount program by forcing pharmaceutical manufacturers to sell drugs at steep discounts to commercial pharmacy chains like Walgreens and CVS.